Fertility warning
This medicine may affect fertility.
Leaflet TRIOXID DE ARSEN TILLOMED 2mg / ml concentrate for solution for infusion
- Product code:
- W71667001
- Quantity:
- 1
- Indicated for:
- acute promyelocytic leukemia
- Route of administration:
- infusion
- Substance:
- arsenic trioxide (antineoplastic agent)
- ATC
- L01XX27 — Antineoplastic and immunomodulating agents | Other antineoplastic agents
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Arsenic trioxide is a medication used in the treatment of acute promyelocytic leukemia (APL), a rare form of leukemia. It works by inducing apoptosis (programmed cell death) in cancer cells and promoting their differentiation into normal cells.
Arsenic trioxide is administered intravenously, usually as part of a combination regimen with other medications such as all-trans retinoic acid (ATRA). It is commonly used in cases of relapsed or refractory APL, as well as a first-line therapy in certain situations.
Common side effects include nausea, fatigue, fever, and elevated liver enzymes. In rare cases, severe complications such as differentiation syndrome or cardiac arrhythmias may occur.
Arsenic trioxide is an essential medication in the treatment of acute promyelocytic leukemia, helping to improve survival rates and patient outcomes.
Arsenic trioxide is administered intravenously, usually as part of a combination regimen with other medications such as all-trans retinoic acid (ATRA). It is commonly used in cases of relapsed or refractory APL, as well as a first-line therapy in certain situations.
Common side effects include nausea, fatigue, fever, and elevated liver enzymes. In rare cases, severe complications such as differentiation syndrome or cardiac arrhythmias may occur.
Arsenic trioxide is an essential medication in the treatment of acute promyelocytic leukemia, helping to improve survival rates and patient outcomes.
General data about TRIOXID DE ARSEN TILLOMED 2mg / ml
- Substance:
- arsenic trioxide
- Date of latest medicines list:
- 01-03-2026
- Product code:
- W71667001
- Concentration:
- 2mg / ml
- Pharmaceutical form:
- concentrate for solution for infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for arsenic trioxide
- 1mg/ml
- 2mg/ml